Novavax Stock Is Rebounding After Covid-19 Vaccines Launch in U.K.

Novavax


stock is climbing in premarket trading Tuesday after the company announced that an initial one million doses of its Covid-19 vaccine are now available for use in the U.K.

Shares of

Novavax


(ticker: NVAX) have struggled this year, tumbling 87% so far in 2022, and 91% in the past 12 months. The company slashed its full-year revenue guidance back in August, and posted a disappointing second quarter amid poor demand for its Covid-19 vaccine.